Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa

Published:2019-07-08 Issue:9 Volume:46 Page:745-751
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Morita Akimichi¹^ORCID,Takahashi Hidetoshi²,Ozawa Kentaro³,Imafuku Shinichi⁴^ORCID,Nakama Takekuni⁵,Takahashi Kenzo⁶,Matsuyama Takashi⁷,Okubo Yukari⁸^ORCID,Kitamura Susumu⁹^ORCID,Matsuda Naoto⁹,Zhao Yiwei⁹,Yokoyama Masayuki⁹,Hayashi Nobukazu¹⁰^ORCID,Terui Tadashi¹¹

Affiliation:

1. Nagoya City University Graduate School of Medical Sciences NagoyaJapan

2. Takagi Dermatological Clinic HokkaidoJapan

3. National Hospital Organization Osaka National Hospital OsakaJapan

4. Fukuoka UniversityFukuoka Japan

5. Kurume University School of Medicine FukuokaJapan

6. University of Ryukyus OkinawaJapan

7. Tokai UniversityTokyo Japan

8. Tokyo Medical UniversityTokyo Japan

9. AbbVie GKTokyo Japan

10. Toranomon HospitalTokyo Japan

11. Nihon University School of Medicine Tokyo Japan

Funder

AbbVie

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.14997

Reference23 articles.

1. Morbidity in patients with hidradenitis suppurativa

2. What causes hidradenitis suppurativa?

3. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study

4. Questionnaire surveillance of hidradenitis suppurativa in Japan

5. Clinical characteristics and epidemiology of hidradenitis suppurativa in Korea: a single‐center study;You HR;Korean J Dermatol,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of infection in patients with hidradenitis suppurativa on biologics or other immunomodulators: a systematic review and meta‐analysis;International Journal of Dermatology;2023-10-27

2. Hidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management—A Systematic Review;Current Issues in Molecular Biology;2023-05-17

3. Advances in biologic and small molecule therapies for hidradenitis suppurativa;Expert Opinion on Pharmacotherapy;2022-05-10

4. Adalimumab effect on pain in hidradenitis suppurativa patients: systematic review and meta-analysis;Dermatology Practical & Conceptual;2022-05-02

5. Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12‐week interim analysis of post‐marketing surveillance in Japan;The Journal of Dermatology;2022-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3